About: Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.
Sector: Healthcare
Industry: Biotechnology
Latest price: $260.81 (-3.44%)
ASNDNASDAQAscendis Pharma AS
Ascendis Pharma AS share price
ASND price activity
Último preço
$ 260,810
Variação (24h)
-9,28 USD (-3,44%)
Volume
476.15K
Volume (média 4 sem.)
-
Abertura
$ 268,72
Variação do dia
$ 260,75 - $ 272,37
Fechamento anterior
$ 270,09
Último negócio
09 Sep, 8:00 pm GMT+0
Atrasado
09 Sep, 8:00 pm GMT+0
ASND price performance
Atrasado
09 Sep, 8:00 pm GMT+0
quote.marketSignals